ANN ARBOR, MI / ACCESSWIRE / November 20, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today announced that the management team will attend the 35th Annual Piper Sandler Healthcare Conference in New York City on November 28, 2023.
Zomedica CEO Larry Heaton will be presenting a Company overview and business outlook at 10:30 a.m. ET. The live webcast of the presentation will be available here.
The presentation will be available for viewing and archived for replay on the Corporate website at https://investors.zomedica.com/.
The management team will host one-on-one meetings with institutional investors at the conference.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit zomedica.com.
Follow Zomedica
Email Alerts: http://investors.zomedica.com
LinkedIn: https://www.linkedin.com/company/zomedica
Facebook: https://m.facebook.com/zomedica
Twitter: https://twitter.com/zomedica
Instagram: https://www.instagram.com/
Investor Contact:
Zomedica Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
1-734-369-2555
For Risk Factors and Forward-Looking Statements, please visit Zomedica.com, Edgar at www.sec.gov and SEDAR at www.sedarplus.ca
| Last Trade: | US$0.13 |
| Daily Change: | 0.0008 0.61 |
| Daily Volume: | 1,027,336 |
| Market Cap: | US$129.350M |
November 14, 2024 November 08, 2024 November 07, 2024 October 24, 2024 October 03, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
